Desmetramadol

N/A

Report date: 2026/01/18 20:00:10
NME

Base Information

Drug NameDesmetramadol
Drug Alias NameOmnitramO-DemethyltramadolO-DesmethyltramadolO-demethyl-tramadolO-desmethyl-tramadol +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterMu opioid receptor
Therapy Area/IndicationsChronic PainPainNeuralgia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSyntrix Biosystems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntrix Biosystems Inc
Active IndicationsN/A
Inactive IndicationsChronic PainPainNeuralgia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A